Replies to post #659403 on NorthWest Biotherapeutics Inc (NWBO)

[Zadie420]

Edited- RYZB got one or two cancer indications on Ph III (one in a niche market for a type of Pancreas cancer). They were bought for $4.1 Bil. Here at NWBO we submitted documents for approval to U.K and planning to apply to other RAs in couple of months. Also, we got other indications we go after once we get an approval from U.K using off shelf. Don't forget about DCVax-D. Hmmmm. Also, they are in crowded treatments. Many competitors.

[jimmy667]

BMY paid $74 billion for Celegene. Let that sink in and hope that NWBO is not sold until many quarters of accelerating earnings.